Production Manager
Join Us in Changing Lives
At OXB, our people are at the heart of everything we do. We’re on a mission to enable life‑changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day: Responsible, Responsive, Resilient, and Respectful.
We’re currently recruiting for a Production Manager to join our Manufacturing team. In this role, you will coordinate the safe day‑to‑day operations and administration of a manufacturing area to meet quality, customer demand and cost targets and deputise for the Head of Manufacturing as required, playing a key part in advancing our mission and making a real difference.
Your responsibilities in this role would be:
* Taking accountability for the successful operation of designated manufacturing areas, including adherence to schedule and quality output.
* Ensuring designated areas compliance with Quality, Safety and Environmental systems and procedures.
* Creating a positive team dynamic and enabling strong team performance and development.
* Implementing agreed manufacturing Key Performance Indicators.
* Developing external client relationships within the Pharma/Biotech industry.
* Co‑ordinating projects and customer needs for manufacturing.
* Deputising for the Head of Manufacturing during absences.
* Taking accountability for bringing together all support functions to keep the area moving forward.
* Performing as the Subject Matter Expert for GMP audits.
We are looking for:
* Degree in a science‑related subject and/or experience of working to GMP standard.
* Strong knowledge of GMP manufacturing and pharmaceutical quality systems.
* Competent at using data to drive decision making and evaluating safety and quality risk.
* Previous facility and people management experience.
About Us:
OXB is a quality and innovation‑led viral vector CDMO with a mission to enable its clients to deliver life‑changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 30 years of experience in viral vectors; the driving force behind the majority of gene therapies.
OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno‑associated virus (AAV) and adenoviral vectors. OXB’s world‑class capabilities span from early‑stage development to commercialisation. These capabilities are supported by robust quality‑assurance systems, analytical methods, and depth of regulatory expertise.
Why Join Us?
* 💸 Competitive total reward packages
* 🧘 Wellbeing programmes that support your mental and physical health
* 🚀 Career development opportunities to help you grow and thrive
* 🤝 Supportive, inclusive, and collaborative culture
* 🧪 State‑of‑the‑art labs and manufacturing facilities
* 🌍 A company that lives its values: Responsible, Responsive, Resilient, Respect
We want you to feel inspired every day. At OXB, we’re future‑focused and growing fast. We succeed together—through passion, commitment, and teamwork.
Ready to Make a Difference?
Collaborate. Contribute. Change lives.
Profile description:
Oxford Biomedica is a quality and innovation‑led viral vector CDMO that enables its clients to deliver life‑changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.
Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA) into a patient’s cells. One highly effective approach to delivering genetic information is to re‑engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (in vivo gene therapy) or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (ex vivo gene therapy or gene‑modified cell therapy).
Oxford Biomedica collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno‑associated virus (AAV) and adenoviral vectors. Oxford Biomedica’s world‑class capabilities span from early‑stage development to commercialisation. These capabilities are supported by robust quality‑assurance systems, analytical methods and depth of regulatory expertise.
#J-18808-Ljbffr